Cipla top bet from pharma space, says Jai Bala

Jai Bala of Cashthechaos.com told CNBC-TV18, "Still, Cipla remains a good bet for me within the pharmaceutical space. It has been oscillating between Rs 570 and Rs 740. If it were to continue a follow-through buying, if you had to see a follow-through buying for the stock, it is looking quite promising.""However, the sector as such is going to be join the bandwagon of the bullish move. Once the frontline stocks like Cipla and Dr Reddy's Labs takes lead but for me the top pick within the sector is Cipla," he said.